KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-Current Assets (2016 - 2025)

Pacific Biosciences Of California has reported Non-Current Assets over the past 16 years, most recently at $409.0 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $409.0 million for Q4 2025, down 46.52% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (down 53.04% YoY), and the annual figure for FY2025 was $409.0 million, down 46.52%.
  • Non-Current Assets for Q4 2025 was $409.0 million at Pacific Biosciences Of California, roughly flat from $408.9 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PACB hit a ceiling of $1.0 billion in Q3 2023 and a floor of $56.6 million in Q2 2021.
  • Median Non-Current Assets over the past 5 years was $905.1 million (2022), compared with a mean of $718.5 million.
  • Biggest five-year swings in Non-Current Assets: surged 1499.18% in 2022 and later tumbled 58.12% in 2025.
  • Pacific Biosciences Of California's Non-Current Assets stood at $905.8 million in 2021, then grew by 1.01% to $915.0 million in 2022, then rose by 9.72% to $1.0 billion in 2023, then dropped by 23.83% to $764.8 million in 2024, then plummeted by 46.52% to $409.0 million in 2025.
  • The last three reported values for Non-Current Assets were $409.0 million (Q4 2025), $408.9 million (Q3 2025), and $412.1 million (Q2 2025) per Business Quant data.